Kennedy Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-9,261
| Closed | -$460K | – | 730 |
|
2018
Q1 | $460K | Buy |
+9,261
| New | +$460K | 0.01% | 700 |
|
2017
Q4 | – | Sell |
-23,825
| Closed | -$1.38M | – | 743 |
|
2017
Q3 | $1.38M | Sell |
23,825
-13,047
| -35% | -$757K | 0.02% | 641 |
|
2017
Q2 | $1.82M | Buy |
+36,872
| New | +$1.82M | 0.03% | 600 |
|
2016
Q2 | – | Sell |
-9,049
| Closed | -$405K | – | 706 |
|
2016
Q1 | $405K | Hold |
9,049
| – | – | 0.01% | 702 |
|
2015
Q4 | $345K | Sell |
9,049
-9,441
| -51% | -$360K | 0.01% | 710 |
|
2015
Q3 | $589K | Sell |
18,490
-5,009
| -21% | -$160K | 0.01% | 683 |
|
2015
Q2 | $776K | Buy |
23,499
+2,145
| +10% | +$70.8K | 0.01% | 686 |
|
2015
Q1 | $879K | Buy |
21,354
+11,157
| +109% | +$459K | 0.02% | 668 |
|
2014
Q4 | $415K | Buy |
+10,197
| New | +$415K | 0.01% | 717 |
|
2014
Q1 | – | Sell |
-18,211
| Closed | -$695K | – | 740 |
|
2013
Q4 | $695K | Buy |
18,211
+3,211
| +21% | +$123K | 0.01% | 676 |
|
2013
Q3 | $358K | Buy |
+15,000
| New | +$358K | 0.01% | 723 |
|